Role of angiotensin receptor-neprilysin inhibitor in diabetic complications

Ying Liu, Cun-Yu Lu, Yi Zheng, Yu-Min Zhang, Ling-ling Qian, Ku-lin Li, Gary Tse, Ru-Xing Wang, Tong Liu
{"title":"Role of angiotensin receptor-neprilysin inhibitor in diabetic complications","authors":"Ying Liu, Cun-Yu Lu, Yi Zheng, Yu-Min Zhang, Ling-ling Qian, Ku-lin Li, Gary Tse, Ru-Xing Wang, Tong Liu","doi":"10.4239/wjd.v15.i5.867","DOIUrl":null,"url":null,"abstract":"Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.","PeriodicalId":509005,"journal":{"name":"World Journal of Diabetes","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4239/wjd.v15.i5.867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血管紧张素受体-肾素抑制剂在糖尿病并发症中的作用
糖尿病是一种多系统表现的常见疾病,在全球范围内造成严重的残疾和死亡负担。血管紧张素受体-奈普利酶抑制剂(ARNI)属于治疗心力衰竭的一类药物,具有降低住院率和死亡率的功效。本综述主要关注与 ARNI 和糖尿病并发症相关的临床和基础研究,讨论可能的生理和分子机制,并对未来的应用提出见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes Glymphatic function and its influencing factors in different glucose metabolism states Management of gestational diabetes mellitus via nutritional interventions: The relevance of gastric emptying Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety Remission of type 2 diabetes mellitus
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1